WENDY FLANSBURG: Open Payments
NPI 1770648503 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$138 in 7 payments from 4 companies in 2025. Trend: 2023 $58 · 2024 $149 · 2025 $138
Food & beverage: $138
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Alkermes, Inc. | 1 | $20 |
Products named: VRAYLAR, CAPLYTA, AUSTEDO XR, ARISTADA.
Industry payments across MT — which companies pay providers there.
